Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Riley Griffin
Stay informed with Riley Griffin’s coverage and analysis for Fortune.
Page 2 of 4
Finance
Johnson & Johnson shares jump as company follows GE and Toshiba in decision to split business apart
By
Riley Griffin
,
John Lauerman
, and others
Health
Moderna defends its COVID-19 vaccine, acknowledges heart risks in young men
By
Riley Griffin
and
Bloomberg
Health
Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it
By
Thomas Mulier
,
Riley Griffin
, and others
Health
Biden administration moves to prevent shortage of COVID-19 antibody treatments
By
Riley Griffin
,
Emma Court
, and others
Health
Moderna seeks full FDA approval for its COVID-19 vaccine
By
Riley Griffin
and
Bloomberg
Health
Johnson & Johnson taps Duato as new CEO, replacing Gorsky
By
Riley Griffin
and
Bloomberg
Health
Pfizer submits early data on the effects of third booster dose to FDA
By
Riley Griffin
,
Robert Langreth
, and others
Health
Pfizer to deliver 200 million vaccines to the U.S. in push to protect kids
By
Riley Griffin
and
Bloomberg
Environment
J&J recalls some Neutrogena and Aveeno sunscreens after carcinogen found
By
Anna Edney
,
Riley Griffin
, and others
Health
Johnson & Johnson says its COVID vaccine helps protect against the delta variant
By
Riley Griffin
and
Bloomberg
Health
U.S. to invest $3.2 billion into COVID antiviral program
By
Riley Griffin
,
Rebecca Torrence
, and others
Health
Pfizer is launching a final study of the COVID-19 vaccine in children under 12
By
Riley Griffin
and
Bloomberg
Health
Merck takes huge hit for its abandoned COVID-19 drug efforts
By
Riley Griffin
and
Bloomberg
Leadership
GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment
By
James Paton
,
Riley Griffin
, and others
Health
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines
By
Riley Griffin
and
Bloomberg